REFERENCES
- Arcamone F. Properties of anti-tumour anthracyclines and new development in their application. Cancer Res. 1985; 45: 5995–5999
- Brown J., Wouters B. Apoptosis, p53, and tumour cell sensitivity to anticancer agents. Cancer Res. 1999; 59: 1391–1399
- Duncan R., Seymour L., O'Hare K., Flangan P., Wedge S., Hume I., Ulbrich K., Strohalm J., Subr V., Speafico F., Grandi M., Ripamonti M., Farao M., Suarato A. Preclinical evaluation of polymer-bound doxorubicin. J. Control. Release 1992; 331–346
- Duncan R., Vicent M. J., Greco F., Nicholson R. I. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer. Endocr. Relat. Cancer 2005; 12: S189–199
- Efstathiou E., Logothetis C. J. Review of late complications of treatment and late relapse in testicular cancer. J. Natl. Compr. Canc. Netw. 2006; 4: 1059–1070
- Hansen M., Nielsen S., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/ cell kill. J. Immuno. Methods 1989; 119: 203–210
- Hayes W., Laws E. Dosage and other factors influencing toxicity. Handb. Pest. Toxicol. 1991; 1: 39–105
- Julicher R., Sterrenberg L., Bast A., Riksen R., Koomen J., Noordhoek J. The role lipid peroxidation in acute doxorubicin induced cardiotoxicity as studied in rat isolated heart. J. Pharm. Pharmacol. 1985; 38: 277–282
- Kawaishi M., Koizum F., Nishio K. Problems associated with molecular targeted drugs for cancer. Gan. To Kagaku Ryoho. 2006; 33: 1373–1379
- Kissel M., Peschke P., Subr V., Ulbrich K., Schuhmacher J., Debus J., Friedrich E. Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors. PDA J. Pharm. Sci. Technol. 2001; 55: 191–201
- Kovár M., Mrkvan T., Strohalm J., Etrych T., Ulbrich K., Stastný M., Ríhová B. HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia. J. Control. Release 2003; 92: 315–330
- Line B. R., Mitra A., Nan A., Ghandehari H. Targeting tumor angiogenesis: comparison of peptide and polymerpeptide conjugates. J. Nucl. Med. 2005; 46: 1552–1560
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immuno. Methods 1983; 65: 55–63
- Rejmanova P., Kopecek J., Pohl J., Baudys M., Kostka V. Degradation of oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide coplymers by bovine spleen cathepsin B. Makromol. Chem. 1983; 184: 2009–2020
- Rogers K., Carr B., Tokes Z. Cell-surface mediated cytotoxicity of polymer bound adriamycin against drug resistance hepatocytes. Cancer Res. 1983; 43: 2741–2748
- Seymour L., Duncan R., Kopeckova P., Kopecek J. Daunomycin-and adriamycin-N(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery. Cancer Treat. Rev. 1987a; 14: 319–327
- Seymour L. W., Duncan R., Strohalm J., Kopecek J. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J. Biomed. Mater. Res. 1987b; 21: 1341–1358
- Tarasiuk J., Frezard F., Garnier-Suilerot A., Gattegno L. Anthracycline incorporation in human lymphocytes. Kinetic of uptake and under concentration. Biochem. Biophys. Acta 1989; 1013: 109–115
- Van Hoff D., Layard M. Risk factors for doxorubicin congestive heart failure. Ann. Intern. Med. 1979; 91: 710–717